<code id='7B33070BA6'></code><style id='7B33070BA6'></style>
    • <acronym id='7B33070BA6'></acronym>
      <center id='7B33070BA6'><center id='7B33070BA6'><tfoot id='7B33070BA6'></tfoot></center><abbr id='7B33070BA6'><dir id='7B33070BA6'><tfoot id='7B33070BA6'></tfoot><noframes id='7B33070BA6'>

    • <optgroup id='7B33070BA6'><strike id='7B33070BA6'><sup id='7B33070BA6'></sup></strike><code id='7B33070BA6'></code></optgroup>
        1. <b id='7B33070BA6'><label id='7B33070BA6'><select id='7B33070BA6'><dt id='7B33070BA6'><span id='7B33070BA6'></span></dt></select></label></b><u id='7B33070BA6'></u>
          <i id='7B33070BA6'><strike id='7B33070BA6'><tt id='7B33070BA6'><pre id='7B33070BA6'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:792
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more
          Albert Bourla of Pfizer: worst biopharma CEO of 2023
          Albert Bourla of Pfizer: worst biopharma CEO of 2023

          HyacinthEmpinado/STATPfizeristhisyear’santi-EliLilly.IfDavidRicksisthebestbiopharmaCEOof2023,thenPfi

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Public health communication lessons from Covid

          KENABETANCUR/AFPviaGettyImagesNowthattheCovid-19publichealthemergencyhasended,it’sawfullytemptingtop